Botswana Blood Products Import Market -- HS Code 3002 Trade Data & Price Trend (Q3 2025)

Botswana Blood Products Import (HS 3002) Key Takeaways

Botswana’s blood products import market under HS Code 3002 in Q3 2025 is dominated by veterinary vaccines (41.6% of value) but features a high-value tier of human biologicals, with prices rebounding sharply to $129.11/kg in September after August’s volatility. The market relies heavily on a few key suppliers, controlling 98% of import value, while South Africa supplies 58.5% of volume but at lower unit prices, highlighting geographic and supply chain risks. This analysis is based on cleanly processed customs data from the yTrade database for Q3 2025.

Botswana Blood Products Import (HS 3002) Background

What is HS Code 3002?

HS Code 3002 covers human and animal blood products, vaccines, toxins, and cultures. These products are critical for medical, pharmaceutical, and research industries, driving stable global demand due to their essential role in healthcare and biotechnology. Botswana's import of these products reflects its reliance on advanced medical supplies to support its healthcare infrastructure.

Current Context and Strategic Position

Botswana's trade policies, including updated customs tariffs and procedures as of July 2025 [BURS], highlight the regulatory framework governing HS Code 3002 imports. The country's strategic position as a net importer of blood products underscores its dependence on international suppliers to meet domestic healthcare needs. Monitoring Botswana's Blood Products Import trends under HS Code 3002 is vital for stakeholders navigating this regulated market. The 2025 tariff updates and trade portal enhancements [Botswana Trade Portal] further emphasize the need for vigilance in tracking hs code 3002 trade data to anticipate supply chain disruptions or policy shifts.

Botswana Blood Products Import (HS 3002) Price Trend

Key Observations

Botswana's Blood Products Import trend for Q3 2025 showed a strong finish, with September imports reaching $2.53 million USD. This performance was driven by a sharp recovery in unit prices, which rose to $129.11/kg after a significant dip in August.

Price and Volume Dynamics

The hs code 3002 value trend exhibited notable volatility through the quarter. August saw a surge in import volume to 59.69K kg, but unit prices collapsed to $19.03/kg, likely reflecting either a temporary supply glut or opportunistic procurement. September then marked a sharp reversal, with both value and unit price rebounding strongly as import volumes normalized. This pattern suggests underlying market sensitivity to supply availability or inventory cycles, common in pharmaceutical commodities where order timing and batch sizes can create pronounced monthly swings. The overall Botswana Blood Products Import trend remains subject to these operational and logistical variables rather than clear policy shifts.

Botswana Blood Products Import (HS 3002) HS Code Breakdown

Product Specialization and Concentration

According to yTrade data, Botswana's HS Code 3002 import market in Q3 2025 is heavily concentrated in veterinary vaccines, which account for 41.6 percent of the total import value. This product, described as vaccines and similar products for veterinary medicine, shows a clear specialization with a moderate unit price of 5.48 USD per kilogram. One shipment of human vaccines stands out as an extreme price anomaly at 7248.80 USD per unit and has been isolated from the main analysis due to its vastly different economic profile.

Value-Chain Structure and Grade Analysis

The remaining imports under Botswana's HS Code 3002 trade data reveal a two-tier structure. The first group consists of high-value, finished human immunological products like antisera and blood fractions, with unit prices ranging from 48 to 470 USD per unit. The second includes other human and veterinary biologicals like toxins and cell cultures, with lower unit prices from 27 to 63 USD per unit. This mix of differentiated finished goods and semi-processed biological materials indicates a market dealing in both specialized manufactured products and more standardized, bulk-oriented items.

Strategic Implication and Pricing Power

For importers of HS Code 3002 into Botswana, pricing power is closely tied to product differentiation. Suppliers of high-value human medicines like antisera and retail-packed immunological products likely maintain strong margins due to regulatory and quality barriers. In contrast, the veterinary vaccine segment, while dominant by volume, operates at lower unit prices, suggesting higher competition and more pressure on costs. Companies should focus on securing reliable sources for high-grade human biologicals while optimizing logistics for bulk veterinary products to manage this dual-market dynamic effectively.

Table: Botswana HS Code 3002) Breakdown Details (Source: yTrade)

Check Detailed HS Code 3002 Breakdown

Botswana Blood Products Import (HS 3002) Origin Countries

Geographic Concentration and Dominant Role

In Q3 2025, SOUTH AFRICA is the dominant source for Botswana's Blood Products imports, holding a 33.36% value share and a much higher 58.52% quantity share. This gap suggests that shipments from South Africa focus on bulk or standard-grade products, rather than high-value items. The high frequency share of 52.35% indicates very regular shipments, likely due to the perishable nature of blood products requiring frequent supply to maintain freshness. Other key partners like Ireland and the UK have lower quantity shares but higher value per unit, pointing to premium product demand.

Origin Countries Clusters and Underlying Causes

The import origins split into two clear clusters based on Botswana's Blood Products trade data. The volume cluster includes South Africa and India, where quantity shares are high at 58.52% and 35.36% respectively, but value shares are lower, implying large-scale purchases of basic or raw material versions. The high-yield cluster consists of Ireland, the UK, France, Denmark, Switzerland, Netherlands, and Uruguay, where value shares exceed quantity shares, signaling imports of specialized or premium blood products. South Africa's high frequency reinforces a transactional supply chain with daily or weekly deliveries to meet urgent medical needs.

Forward Strategy and Supply Chain Implications

Botswana's heavy reliance on South Africa for volume in Blood Products imports creates supply chain vulnerability, as disruptions could affect availability. Diversifying sources toward high-yield partners like Ireland or the UK could reduce risk and ensure access to critical premium products. Analyzing HS Code 3002 trade patterns highlights the need for a balanced sourcing strategy that mixes bulk purchases with niche suppliers to stabilize Botswana's healthcare supply chains.

Table: Botswana Blood Products (HS 3002) Top Origin Countries (Source: yTrade)

Get Complete Origin Countries Profile

Botswana Blood Products (HS 3002) Suppliers Analysis

Supplier Concentration and Dominance

In Q3 2025, Botswana's blood products import market is tightly controlled by a small set of suppliers. According to yTrade data, high-value and high-frequency suppliers dominate, accounting for 98.02% of the import value and 83.03% of shipment frequency. This means almost all trade comes from a few reliable, high-volume partners.

Strategic Supplier Clusters and Trade Role

Other suppliers are low-value but still frequent, making up 16.97% of shipments but only 1.98% of value. Companies like RCPAQAP PTY LTD and ABBVIE operate here, likely as niche or secondary sources. The profile of HS code 3002 suppliers in the dominant group, including IRVINES AFRICA LTD and BE VACCINES PTE LTD, points to direct manufacturers or key distributors, suggesting a direct sourcing model without heavy intermediation.

Sourcing Strategy and Vulnerability

Botswana's heavy reliance on a few suppliers for blood imports creates vulnerability to supply disruptions. Strategic focus should be on diversifying sources or securing backup agreements. The recent updates to Botswana's trade procedures, as noted in the Botswana Trade Portal and BURS, may help streamline imports and reduce administrative risks, supporting a more resilient supply chain.

Table: Botswana Blood Products (HS 3002) Top Suppliers List (Source: yTrade)

Check Full Blood Products Supplier lists

Action Plan for Blood Products Market Operation and Expansion

• Diversify sourcing beyond South Africa by adding high-yield partners like Ireland and the UK, using hs code 3002 trade data to identify them; this reduces supply risk for Botswana's Blood Products Import and ensures access to critical premium products.
• Negotiate directly with the dominant high-value suppliers to secure favorable long-term contracts; this leverages their market position to stabilize pricing and availability within the Blood Products supply chain.
• Optimize logistics for high-frequency, bulk veterinary vaccines from South Africa by implementing just-in-time delivery; this minimizes inventory costs and preserves product efficacy for the Botswana Blood Products Import market.
• Develop contingency plans with low-frequency, niche suppliers to serve as backup sources; this builds resilience into the Blood Products supply chain against disruptions from primary partners.
• Streamline customs clearance using Botswana's updated trade procedures to accelerate perishable shipments; this reduces administrative delays that threaten the stability of Botswana's Blood Products Import operations.

Take Action Now —— Explore Botswana Blood Products Import Data

Frequently Asked Questions

Q1. What is driving the recent changes in Botswana Blood Products Import 2025 Q3?

The volatility in Botswana's Blood Products imports is driven by sharp price fluctuations, with unit prices rebounding to $129.11/kg in September after a dip to $19.03/kg in August, likely due to supply gluts or inventory cycles.

Q2. Who are the main origin countries of Botswana Blood Products (HS Code 3002) 2025 Q3?

South Africa dominates with 33.36% of import value and 58.52% of quantity, followed by Ireland and the UK, which supply higher-value products.

Q3. Why does the unit price differ across origin countries of Botswana Blood Products Import?

Price differences stem from product specialization: South Africa and India focus on bulk veterinary vaccines (lower-priced), while Ireland and the UK supply premium human biologicals like antisera (higher-priced).

Q4. What should importers in Botswana focus on when buying Blood Products?

Importers should prioritize diversifying suppliers to reduce reliance on South Africa for bulk products while securing high-value human biologicals from premium partners like Ireland.

Q5. What does this Botswana Blood Products import pattern mean for overseas suppliers?

Suppliers of high-value human biologicals (e.g., Ireland, UK) have stable demand, while bulk veterinary vaccine exporters (e.g., South Africa) face cost competition but benefit from high shipment frequency.

Q6. How is Blood Products typically used in this trade flow?

Botswana imports both finished human immunological products (e.g., antisera) for medical use and veterinary vaccines for livestock health, reflecting a dual-market demand.

Detailed Monthly Report

Botswana HS3002 Import Snapshot 2025 JUL

Botswana HS3002 Import Snapshot 2025 AUG

Botswana HS3002 Import Snapshot 2025 SEP